EGFL7 is proposed to have roles in angiogenesis (85, 86) and the promotion of cell motility in human cancers (e.g. hepatocellular carcinoma (87), prostate cancer (88), and gastric cancer (89)). This evidence concerns the gene EGFL7 and prostate carcinoma.